Discontinue oral meds if appropriate response to minimally invasive procedure but restart if efficacy not maintained EO nbsp nbsp If good tx response There s likely no added benefit to continuing OAB meds are assoc w polypharmacy added cost and potential

Discontinue oral meds if appropriate response to minimally invasive procedure, but restart if efficacy not maintained. [EO]<br>
&nbsp;&nbsp;◦ If good tx response: There’s likely no added benefit to continuing OAB meds; are assoc w/ polypharmacy, added cost, and potential side effects.